← FDA DRUG APPROVALS

FDA ANDA · ANDA075136

VERAPAMIL HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA075136
TYPE
ANDA
ORIGINAL APPROVAL
1998-10-20
LATEST ACTION
2021-12-20
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

VERAPAMIL HYDROCHLORIDEDiscontinued
VERAPAMIL HYDROCHLORIDE 10MG/4ML (2.5MG/ML) · SOLUTION · INTRAVENOUS

Approval history

2021-12-20Labeling · Supplement 14 · standardAP
2021-12-20Labeling · Supplement 12 · standardAP
1998-10-20OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →